Holen Sie sich die Stockscreener-App
4.27
2.15%
0.09
Handel nachbörslich:
4.26
-0.010
-0.23%
Schlusskurs vom Vortag:
$4.18
Offen:
$4.24
24-Stunden-Volumen:
1.02M
Relative Volume:
0.80
Marktkapitalisierung:
$263.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.81M
KGV:
-2.2713
EPS:
-1.88
Netto-Cashflow:
$74.30M
1W Leistung:
+10.62%
1M Leistung:
+16.99%
6M Leistung:
-53.18%
1J Leistung:
+3.39%
1-Tages-Spanne:
$4.13
$4.30
1-Wochen-Bereich:
$3.695
$4.30
52-Wochen-Spanne:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Firmenname
Omeros Corporation
Sektor
Branche
Telefon
206-676-5000
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Vergleichen Sie OMER mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
4.27 | 277.90M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-12-08 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2021-10-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-09-27 | Eingeleitet | JP Morgan | Neutral |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-08-21 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-14 | Bestätigt | Maxim Group | Buy |
| 2019-05-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-03-05 | Herabstufung | Needham | Buy → Hold |
| 2017-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Bestätigt | Maxim Group | Buy |
| 2017-03-17 | Bestätigt | Needham | Buy |
| 2016-11-16 | Bestätigt | Wedbush | Outperform |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-06-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-02 | Bestätigt | Needham | Buy |
| 2016-02-29 | Bestätigt | Wedbush | Outperform |
| 2015-11-11 | Bestätigt | Needham | Buy |
| 2015-08-18 | Bestätigt | WBB Securities | Strong Buy |
| 2015-08-10 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Omeros Corporation Aktie (OMER) Neueste Nachrichten
Omeros Corporation to Announce Q2 Financial Results on August 14, 2025 - AInvest
What indicators show strength in Omeros CorporationFree Trade Setups With Clear Risk Limits - Newser
Can Omeros Corporation rally from current levelsShort Term Profit Strategy with Entry Cues - Newser
Omeros Corporation’s Price Action Aligns with Quant SignalsRisk Managed Intraday Trade Alerts Increase in Volume - 선데이타임즈
Press Release: Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025 - 富途牛牛
Omeros Announces Q2 2025 Earnings Release and Conference Call on August 14 - AInvest
A&O Shearman advises D. Boral Capital LLC on USD22 million registered direct offering of Omeros Corporation - A&O Shearman
Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025 - The Joplin Globe
Omeros Corporation stock daily chart insightsGrowth Summary Based on Market Positioning - Newser
Will earnings trigger a reversal in Omeros CorporationPrice Forecast Based on AI Analysis - Newser
Does Omeros Corporation fit your quant trading modelBuy Candidate Summary Based on Fundamentals - Newser
Volatility clustering patterns for Omeros CorporationFree Exit Ready Momentum Stock Watchlist - Newser
How institutional ownership impacts Omeros Corporation stockLong-Term Trend Tracking and Signal Summary - Newser
Omeros Corporation shares rise 1.32% premarket after positive investor sentiment in Europe. - AInvest
Seattle biopharma raises $22 million through stock sale - The Business Journals
Omeros announces pricing of $22 million registered direct offering - MSN
Omeros Corporation Stock Analysis and ForecastGet daily expert analysis for smarter investing - Jammu Links News
What is the dividend policy of Omeros Corporation stockConsistent triple returns - Jammu Links News
Omeros rises after pricing ~$22M stock offering - MSN
What institutional investors are buying Omeros Corporation stockMassive wealth growth - Jammu Links News
How strong is Omeros Corporation company’s balance sheetExceptional trading performance - Jammu Links News
What catalysts could drive Omeros Corporation stock higher in 2025Discover stocks with explosive upside potential - Jammu Links News
Why is Omeros Corporation stock attracting strong analyst attentionFree Stock Movement Tracking - Jammu Links News
How many analysts rate Omeros Corporation as a “Buy”Proven strategies for superior portfolio growth - Jammu Links News
How volatile is Omeros Corporation stock compared to the marketFree Trading Strategy Suggestions - Jammu Links News
When is Omeros Corporation stock expected to show significant growthPhenomenal investment performance - Jammu Links News
Is Omeros Corporation a good long term investmentAchieve rapid portfolio growth with smart picks - Jammu Links News
What is Omeros Corporation company’s growth strategyGet daily updates on promising stocks - Jammu Links News
Narsoplimab Study Insights Could Boost Omeros (OMER) Amid Eculizumab Concerns - AInvest
Is Omeros Corporation a growth stock or a value stockInvest smarter with comprehensive market analysis - Jammu Links News
What makes Omeros Corporation stock price move sharplyUnlock the power of real-time market data - jammulinksnews.com
What are Omeros Corporation company’s key revenue driversBuild a portfolio that withstands market volatility - Jammu Links News
Why Omeros Corporation stock attracts strong analyst attentionFree Real Time Trade Opportunity Alerts - Newser
Omeros Corporation Recovery Potential Based on Technical ToolsBreakout Momentum Picks With Protection Outlined - metal.it
Best data tools to analyze Omeros Corporation stockFree Daily Profit Focused Stock Screener - Newser
New Product Launches: Will They Boost Omeros Corporation Stock in 2025Free Consistent Profit Pattern Recognition Tools - Newser
Signal strength of Omeros Corporation stock in tech scanners3-Day Market Movement Forecast Analysis - Newser
How does Omeros Corporation generate profit in a changing economyChart Pattern Insights Backed By Experts - Jammu Links News
D. Boral Capital Acted as Exclusive Placement Agent to Omeros Corporation (Nasdaq: OMER) in Connection with its $22,000,000 Registered Direct Offering - ACCESS Newswire
Bank of New York Mellon Corp Increases Stock Holdings in Omeros Corporation (NASDAQ:OMER) - Defense World
Trend analysis for Omeros Corporation this weekReliable Setup Screener with Low Risk - Newser
Moving Average Trends for Omeros Corporation Stock: What They IndicateTechnical Stock Breakout Predictions Signal Entry Points - metal.it
How Omeros Corporation stock performs during market volatilityPrice Movement and Market Sentiment Analysis - Newser
Visual analytics tools that track Omeros Corporation performanceExit Strategy Guide With Risk Control Plan - Newser
Backtesting results for Omeros Corporation trading strategiesFree Safe Entry Stock Watch Suggestions - Newser
Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost - MSN
Omeros Shares Rise After $22 Million Direct Offering Prices - 富途牛牛
Is Omeros Corporation a Top Dividend Stock to Watch in 2025Free Proven Entry Plan With Low Risk Trade - Newser
These Numbers Prove Just How Vibrant The Omeros Corporation (NASDAQ: OMER) Stock Has Been - Stocksregister
Is it the right time to buy Omeros Corporation stockUnlock powerful stock screening techniques - Jammu Links News
Finanzdaten der Omeros Corporation-Aktie (OMER)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):